Increased rate of tumor cell death caused by polyamine synthesis inhibitors
Abstract:
This investigation was designed to determine whether cell death plays a role in the antiproliferative action exerted by polyamine synthesis inhibitors. To estimate the rate of tumor cell death, we measured the loss of 125I from mice harboring Ehrlich ascites tumor cells in which DNA was labeled with 5-125I-iodo-2'-deoxyuridine. DL-alpha-difluoromethylornithine (0.85 mumoles/g body weight/6 h), and enzyme-activated irreversible inhibitor of ornithine decarboxylase, and methylglyoxal-bis(guanylhydrazone) (45 nmoles/g body weight/6 h), an inhibitor of S-adenosylmethionine decarboxylase, were both found to increase the rate of 125I excretion. Our data suggest that these polyamine synthesis inhibitors provoke an increase in the rate of tumor cell death beyond that normally occurring during growth, methylglyoxal-bis(guanylhydrazone) being considerably more potent than DL-alpha-difluoromethylornithine. These in vivo data were corroborated by a study where the host-mediated responses did not have to be considered. Thus, Ehrlich ascites tumor cells were adapted for suspension growth in culture and treated with methylglyoxal-bis(guanylhydrazone) or DL-alpha-difluoromethylornithine. The growth kinetics and the colony forming efficiency of the drug-treated cells clearly show that polyamine synthesis inhibitors not only slow the growth rate but also cause an increase in tumor cell death.
Insights
Polyamine synthesis inhibitors increase tumor cell death. Methylglyoxal-bis(guanylhydrazone) is more potent than DL-alpha-difluoromethylornithine in reducing tumor cell proliferation and survival.
Area of Science:
- Oncology
- Biochemistry
- Pharmacology
Background:
- Polyamines are essential for cell growth and proliferation.
- Inhibiting polyamine synthesis is a potential anti-cancer strategy.
- The role of cell death in the antiproliferative effects of these inhibitors requires elucidation.
Purpose of the Study:
- To determine if cell death contributes to the antiproliferative effects of polyamine synthesis inhibitors.
- To quantify tumor cell death induced by specific polyamine synthesis inhibitors.
- To compare the potency of DL-alpha-difluoromethylornithine and methylglyoxal-bis(guanylhydrazone) in inducing tumor cell death.
Main Methods:
- In vivo studies using mice with Ehrlich ascites tumor cells labeled with 5-125I-iodo-2'-deoxyuridine to measure 125I excretion as an indicator of cell death.
- In vitro studies culturing Ehrlich ascites tumor cells in suspension and treating them with inhibitors.
- Assessing tumor cell death through growth kinetics and colony-forming efficiency assays.
Main Results:
- Both DL-alpha-difluoromethylornithine (ornithine decarboxylase inhibitor) and methylglyoxal-bis(guanylhydrazone) (S-adenosylmethionine decarboxylase inhibitor) increased 125I excretion, indicating enhanced tumor cell death in vivo.
- Methylglyoxal-bis(guanylhydrazone) demonstrated greater potency in increasing tumor cell death compared to DL-alpha-difluoromethylornithine.
- In vitro studies confirmed that these inhibitors not only slow tumor cell growth but also significantly increase tumor cell death.
Conclusions:
- Polyamine synthesis inhibitors demonstrably induce tumor cell death, contributing to their antiproliferative action.
- Methylglyoxal-bis(guanylhydrazone) is a more potent inducer of tumor cell death than DL-alpha-difluoromethylornithine.
- These findings support the therapeutic potential of polyamine synthesis inhibitors in cancer treatment by promoting tumor cell death.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
Abnormal Proliferation
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Drugs that Destabilize Microtubules
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase


